Volume 17, Issue 8 (August 2019)                   IJRM 2019, 17(8): 533-542 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saei Ghare Naz M, Ramezani Tehrani F, Alavi Majd H, Ahmadi F, Ozgoli G, Rashidi Fakari F et al . The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis. IJRM 2019; 17 (8) :533-542
URL: http://ijrm.ir/article-1-1614-en.html
The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis
Marzieh Saei Ghare Naz1 , Fahimeh Ramezani Tehrani2 , Hamid Alavi Majd3 , Fazlollah Ahmadi4 , Giti Ozgoli * 5, Farzaneh Rashidi Fakari6 , Vida Ghasemi6
1- Student Research Committee, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Department of Nursing, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
5- Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran , gozgoli@gmail.com
6- Student Research Committee, Midwifery and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:   (3870 Views)
Abstract
Background: Polycystic ovarian syndrome is an endocrine disorder with many complications. This syndrome is a growing concern among adolescents around the world, with varying reports of its prevalence in different parts of the world.
Objective: This study aimed to determine the prevalence of polycystic ovary syndrome in adolescents by a systematic review and meta-analysis.
Materials and Methods: In this study, a search for published articles with an English language limitation and without a time limit was done in different databases (Scopus, PubMed, and Web of Science, Emabse and Cochrane) in January 2019. The 12 studies that met the criteria for entering a qualitative assessment scale of 5 and higher were subjected to systematic review and meta-analysis. Egger and Begg's tests were used to check the publication bias. Data were analyzed with STATA software, version 11.1.
Results: Twelve studies were included for meta-analysis. The total number of participants in the study was 149,477. The average quality score of all studies was 8.67 (range: 5-10). The prevalence of polycystic ovarian syndrome in adolescents based on the Rotterdam criteria was 11.04% (95% CI: 6.84-16.09%), based on the National Institute of Health criteria, it was 3.39% (95% CI: 0.28-9.54%), and based on Androgen Excess and Polycystic Ovary Syndrome Society, it was 8.03% (95% CI: 6.24-10.01%)
Conclusion: The result of this study showed that there is a variation in the prevalence of PCOS in adolescents based on different criteria; we suggest more community-based studies among adolescences in different parts of the world.
 
Keywords: Polycystic ovary syndrome, Prevalence, Meta-analysis, Adolescence
Full-Text [PDF 551 kb]   (1366 Downloads) |   |   Full-Text (HTML)  (578 Views)  
Type of Study: Review Article |
References
1. Pasquali R. Contemporary approaches to the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab 2018; 9: 123-134. [DOI:10.1177/2042018818756790] [PMID] [PMCID]
2. Farooq R. Short Review on Polycystic Ovarian Syndrome. Journal of Medicine. 2018; 19: 49-53. [DOI:10.3329/jom.v19i1.34843]
3. Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget 2017; 8: 96351-96358. [DOI:10.18632/oncotarget.19180] [PMID] [PMCID]
4. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2013; 6: 1-13. [DOI:10.2147/CLEP.S37559] [PMID] [PMCID]
5. Diamanti-Kandarakis E. PCOS in adolescents. Best Pract Res Clin Obstet Gynaecol 2009; 24: 173-183. [DOI:10.1016/j.bpobgyn.2009.09.005] [PMID]
6. El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly cystic ovarian syndrome: an updated overview. Front Physiol 2016; 7: 124. [DOI:10.3389/fphys.2016.00124] [PMID] [PMCID]
7. Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J Clin Endocrinol Metab 2015; 100: 911-919. [DOI:10.1210/jc.2014-3886] [PMID]
8. Bazarganipour F, Taghavi SA, Montazeri A, Ahmadi F, Chaman R, Khosravi A. The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis. Iran J Reprod Med 2015; 13: 61-70.
9. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes 2008; 32: 1035-1041. [DOI:10.1038/ijo.2008.61] [PMID]
10. Rosenfield RL. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 787-796. [DOI:10.1210/jc.2006-2012] [PMID]
11. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47. [DOI:10.1093/humrep/deh098] [PMID]
12. Carmina E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecol 2004; 56: 1-6.
13. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245. [DOI:10.1210/jc.2006-0178] [PMID]
14. Pfeifer SM, Kives S. Polycystic ovary syndrome in the adolescent. Obstet Gynecol Clin Noth Am 2009; 36: 129-152. [DOI:10.1016/j.ogc.2008.12.004] [PMID]
15. Driscoll DA. Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci 2003; 997: 49-55. [DOI:10.1196/annals.1290.006] [PMID]
16. Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, Ibáñez L, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr 2015; 83: 376-389. [DOI:10.1159/000375530] [PMID]
17. Williams RM, Ong KK, Dunger DB. Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol 2013; 373: 61-67. [DOI:10.1016/j.mce.2013.01.005] [PMID]
18. Merino PM, Codner E, Cassorla F. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence. Arq Bras Endocrinol Metabol 2011; 55: 590-598. [DOI:10.1590/S0004-27302011000800013] [PMID]
19. Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Transl Pediatr 2017; 6: 248-255. [DOI:10.21037/tp.2017.09.11] [PMID] [PMCID]
20. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551. [DOI:10.1093/humrep/dep399] [PMID]
21. Shannon M, Wang Y. Polycystic ovary syndrome: a common but often unrecognized condition. J Midwifery Womens Health 2012; 57: 221-230. [DOI:10.1111/j.1542-2011.2012.00161.x] [PMID]
22. Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab 2014; 18: 317-324. [DOI:10.4103/2230-8210.131162] [PMID] [PMCID]
23. Kaewnin J, Vallibhakara O, Arj-Ong Vallibhakara S, Wattanakrai P, Butsripoom B, Somsook E, et al. Prevalence of polycystic ovary syndrome in Thai University adolescents. Gynecol Endocrinol 2018; 34: 476-480. [DOI:10.1080/09513590.2017.1409716] [PMID]
24. Asgharnia M, Mirblook F, Soltani M. The prevalence of polycystic ovary syndrome (PCOS) in high school students in Rasht in 2009 according to NIH criteria. Int J Fertil Steril 2011; 4: 156-159.
25. Esmaeilzadeh S, Delavar MA, Amiri M, Khafri S, Pasha NG. Polycystic ovary syndrome in Iranian adolescents. Int J Adolesc Med Health 2014; 26: 559-565. [DOI:10.1515/ijamh-2013-0335] [PMID]
26. Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 2014; 3: 123-128. [DOI:10.15171/ijhpm.2014.71] [PMID] [PMCID]
27. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. [DOI:10.1136/bmj.315.7109.629] [PMID] [PMCID]
28. Freeman MF, Tukey JW. Transformations related to the angular and the square root. The Annals of Mathematical Statistics 1950; 21: 607-611. [DOI:10.1214/aoms/1177729756]
29. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 2015; 4: 1. [DOI:10.1186/2046-4053-4-1] [PMID] [PMCID]
30. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011; 24: 223-227. [DOI:10.1016/j.jpag.2011.03.002] [PMID]
31. Akbarzadeh M, Naderi T, Dabbagh Manesh MH, Tabatabaee HR. The frequency of various phenotypes of polycystic ovarian syndrome in adolescents, based on rotterdam criteria. Int J School Health 2015; 2: e26512. [DOI:10.17795/intjsh-26512]
32. Sharif E, Rahman S, Zia Y, Rizk NM. The frequency of polycystic ovary syndrome in young reproductive females in Qatar. Int J Womens Health 2016; 9: 1-10. [DOI:10.2147/IJWH.S120027] [PMID] [PMCID]
33. Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011; 62: 238-242.
34. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 2011; 9: 39. [DOI:10.1186/1477-7827-9-39] [PMID] [PMCID]
35. Ybarra M, Franco RR, Cominato L, Sampaio RB, Sucena da Rocha SM, Damiani D. Polycystic Ovary syndrome among obese adolescents. J Gynecol Endocrinol 2018; 34: 45-48. [DOI:10.1080/09513590.2017.1359250] [PMID]
36. Jalilian A, Kiani F, Sayehmiri F, Sayehmiri K, Khodaee Z, Akbari M. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis. Iran J Reprod Med 2015; 13: 591-604.
37. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2016; 31: 2841-2855. [DOI:10.1093/humrep/dew218] [PMID]
38. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol 2014; 174: 100-105. [DOI:10.1016/j.ejogrb.2013.12.018] [PMID]
39. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016; 106: 6-15. [DOI:10.1016/j.fertnstert.2016.05.003] [PMID]
40. Varanasi LC, Subasinghe A, Jayasinghe YL, Callegari ET, Garland SM, Gorelik A, et al. Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16-29 years. Aust N Z J Obstet Gynaecol 2018; 58: 222-233. [DOI:10.1111/ajo.12730] [PMID]
41. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98: 4565-4592. [DOI:10.1210/jc.2013-2350] [PMID] [PMCID]
42. Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol 2011; 4: 45-51.
43. Bharathi RV, Swetha S, Neerajaa J, Madhavica JV, Janani DM, Rekha SN, et al. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J 2017; 22: 313-316. [DOI:10.1016/j.mefs.2017.05.007]
44. Tehrani FR, Rashidi H, Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran lipid and glucose study. Reprod Biol Endocrinol 2011; 9: 144. [DOI:10.1186/1477-7827-9-144] [PMID] [PMCID]
45. Desai NA, Tiwari RY, Patel SS. Prevalence of polycystic ovary syndrome and its associated risk factors among adolescent and young girls in ahmedabad region. Indian Journal of Pharmacy Practice 2018; 11: 119-125. [DOI:10.5530/ijopp.11.3.27]
46. Christensen SB, Black MH, Smith N, Martinez MM, Jacobsen SJ, Porter AH, et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril 2013; 100: 470-477. [DOI:10.1016/j.fertnstert.2013.04.001] [PMID] [PMCID]
47. Bhuvanashree N, Gupta S, Anitha M, Venkatarao E. Polycystic ovarian syndrome: Prevalence and its correlates among adolescent girls. Ann Trop Med Public Health 2013; 6: 632-636. [DOI:10.4103/1755-6783.140233]
48. Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, Norman RJ, et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod 2011; 26: 1469-1477. [DOI:10.1093/humrep/der102] [PMID]
49. Salehpour S, Esmaeilnia Shirvani H, Entezari A. Evaluation of the prevalence of polycystic ovarian syndrome among adolescent (15-18 Years Old) girls in Tehran during 2005-2006. Int J Fertil Steril 2010; 4: 122-127.
50. Hashemipour M, Faghihimani S, Zolfaghary B, Hovsepian S, Ahmadi F, Haghighi S. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Horm Res 2004; 62: 278-282. [DOI:10.1159/000081842] [PMID]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb